3,4,5,6,7,8-hexahydroquinazolin-4-one, 99.98%, 25g

Oxion Inverso OX.2053-PLPH-ICSI with LWD Plan phase 10x/20x/40x objectives, ICSI equipment and XY cross table

(2-Methylpyridin-4-yl)methanol, 95.0%, 1g

4-Benzyloxan-4-amine hydrochloride, 1g

1-(3-Bromopyridin-2-yl)propan-1-one, 97.0%, 250mg

(4-Sulfamoyl-phenoxy)-acetic acid, 250mg

Methyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-naphthoate, 95.0%, 1g

(3-AMINOCYCLOBUTYL)ACETIC ACID, 95.0%, 100mg

1-(2-Bromo-phenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 10g

3-(Aminomethyl)-6-methyl-4-propylpyridin-2(1H)-one, 95.0%, 250mg

2-Chloro-6-(methylsulfonyl)benzo[d]thiazole, 95.0%, 500mg

2-Nitrobenzene-1,3,5-triol, 98.0%, 1g

Aluminium nitrate nonahydrate 98%, extra pure 250 gram